XOMA Royalty Corporation (XOMA)
(Delayed Data from NSDQ)
$25.84 USD
-0.58 (-2.20%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $26.13 +0.29 (1.12%) 5:00 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
XOMA Royalty Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
XOMA 25.84 -0.58(-2.20%)
Will XOMA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for XOMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XOMA
Novavax (NVAX) Q2 Earnings and Revenues Top Estimates
XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
XOMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates
Stoke Therapeutics (STOK) Soars 12.0%: Is Further Upside Left in the Stock?
What Makes XOMA Royalty (XOMA) a New Buy Stock
Other News for XOMA
I'm Staying Neutral On XOMA Royalty After The LAVA And HilleVax Deals
XOMA Royalty Breaks Above 200-Day Moving Average - Bullish for XOMA
XOMA Royalty to acquire cancer drug developer LAVA Therapeutics
XOMA Royalty (XOMA) to Acquire HilleVax (HLVX) in Cash Deal
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1. ...